Save your place

Sign in to WhoBought

Please try again later.

ArriVent BioPharma, Inc. Common Stock (AVBP) institutional ownership

Latest close $31.73 Jul 24, 2026
Market cap$685M 52-week range SectorHealthcare
Funds holding · Q1 2026
132
reported AVBP position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
87 buyers · 45 sellers

ArriVent BioPharma, Inc. Common Stock (AVBP) price and institutional activity

Dates

Q1 2026

$0 bought by 87 investors
Vivo Capital, LLCPoint72 Asset Management, L.P. +85 more
$0 sold by 45 investors
FMR LLCAihc Capital Management Ltd +43 more
Bought Sold Totals per quarter; hover a bar for the names.

ArriVent BioPharma, Inc. Common Stock (AVBP) institutional activity · 132

Investor Type Est. change Change Δ Own Date
Vivo Capital, LLC · New
Change +886K Date Q1 2026
Vivo Capital, LLC New· Q1 2026 +886K Q1 2026
FMR LLC · Reduced
Change −687K Δ Own −18.6% Date Q1 2026
FMR LLC Reduced· Q1 2026 −687K −18.6% Q1 2026
Aihc Capital Management Ltd · Exited
Change −645K Δ Own −100.0% Date Q1 2026
Aihc Capital Management Ltd Exited· Q1 2026 −645K −100.0% Q1 2026
Point72 Asset Management, L.P. · Added
Change +532K Δ Own +245.3% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +532K +245.3% Q1 2026
Balyasny Asset Management L.P. · Added
Change +383K Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +383K Q1 2026
Logos Global Management LP · New
Change +350K Date Q1 2026
Logos Global Management LP New· Q1 2026 +350K Q1 2026
State Street · Added
Change +329K Date Q1 2026
State Street Added· Q1 2026 +329K Q1 2026
Suvretta Capital Management, LLC · Added
Change +295K Date Q1 2026
Suvretta Capital Management, LLC Added· Q1 2026 +295K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −292K −63.8% Q1 2026
Nomura Holdings Inc · New
Change +242K Date Q1 2026
Nomura Holdings Inc New· Q1 2026 +242K Q1 2026
Rosalind Advisors, Inc. · Exited
Change −216K Δ Own −100.0% Date Q1 2026
Rosalind Advisors, Inc. Exited· Q1 2026 −216K −100.0% Q1 2026
Susquehanna International Group, LLP · Reduced
Change −212K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −212K Q1 2026
Vanguard · Added
Change +162K Date Q1 2026
Vanguard Added· Q1 2026 +162K Q1 2026
BlackRock · Added
Change +157K Date Q1 2026
BlackRock Added· Q1 2026 +157K Q1 2026
Hidden Lake Asset Management LP · Exited
Change −152K Δ Own −100.0% Date Q1 2026
Hidden Lake Asset Management LP Exited· Q1 2026 −152K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 132

Famous investor activity in ArriVent BioPharma, Inc. Common Stock (AVBP)

ArriVent BioPharma, Inc. Common Stock (AVBP) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Parsey Merdad · Director Grant (A) 14K
Owned 14K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Parsey Merdad Director Grant (A) 14K 14K Jun 18, 2026 Jun 22, 2026
Peterson Kristine · Director Grant (A) 14K
Owned 14K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Peterson Kristine Director Grant (A) 14K 14K Jun 18, 2026 Jun 22, 2026
Hohneker John · Director Grant (A) 14K
Owned 14K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Hohneker John Director Grant (A) 14K 14K Jun 18, 2026 Jun 22, 2026
Nolet Chris · Director Grant (A) 14K
Owned 14K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Nolet Chris Director Grant (A) 14K 14K Jun 18, 2026 Jun 22, 2026
Lachapelle Robin · Officer Grant (A) 130K
Owned 130K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Lachapelle Robin Officer Grant (A) 130K 130K Feb 2, 2026 Feb 4, 2026
Lutzker Stuart · Director, Officer Grant (A) 150K
Owned 150K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Lutzker Stuart Director, Officer Grant (A) 150K 150K Feb 2, 2026 Feb 4, 2026
Kung Winston · Officer Grant (A) 140K
Owned 140K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Kung Winston Officer Grant (A) 140K 140K Feb 2, 2026 Feb 4, 2026
Yao Zhengbin · Director, Officer Grant (A) 550K
Owned 550K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Yao Zhengbin Director, Officer Grant (A) 550K 550K Feb 2, 2026 Feb 4, 2026
Kastenmayer James Paul · Officer Grant (A) 130K
Owned 130K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Kastenmayer James Paul Officer Grant (A) 130K 130K Feb 2, 2026 Feb 4, 2026
Hhlr Advisors, Ltd. · 10% Owner Sell −$13M
Price $23.37 Qty −556K Owned 3.9M Trade date Dec 10, 2025 Filed date Feb 3, 2026
Hhlr Advisors, Ltd. 10% Owner Sell $23.37 −556K −$13M 3.9M Dec 10, 2025 Feb 3, 2026
10 of 10

ArriVent BioPharma, Inc. Common Stock (AVBP) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Hhlr Advisors, Ltd. 4.5M
% of shares outstanding 13.4% Filing date Nov 14, 2024
Hhlr Advisors, Ltd. 4.5M 13.4% Nov 14, 2024
Orbimed Advisors LLC 3.0M
% of shares outstanding 9.1% Filing date Feb 5, 2024
Orbimed Advisors LLC 3.0M 9.1% Feb 5, 2024
FMR LLC 3.0M
% of shares outstanding 6.8% Filing date May 6, 2026
FMR LLC 3.0M 6.8% May 6, 2026
FMR LLC 2.1M
% of shares outstanding 6.3% Filing date Nov 12, 2024
FMR LLC 2.1M 6.3% Nov 12, 2024
Lav Fund Vi, L.P. 2.0M
% of shares outstanding 6.2% Filing date Feb 13, 2024
Lav Fund Vi, L.P. 2.0M 6.2% Feb 13, 2024
Suvretta Capital Management, LLC 2.0M
% of shares outstanding 6.1% Filing date Dec 4, 2024
Suvretta Capital Management, LLC 2.0M 6.1% Dec 4, 2024
Octagon Capital Advisors LP 2K
% of shares outstanding 5.9% Filing date Oct 11, 2024
Octagon Capital Advisors LP 2K 5.9% Oct 11, 2024
Blackrock, Inc. 1.9M
% of shares outstanding 5.8% Filing date Nov 8, 2024
Blackrock, Inc. 1.9M 5.8% Nov 8, 2024
8 of 9

ArriVent BioPharma, Inc. Common Stock (AVBP) ownership FAQ

Who owns AVBP?

132 reporting institutions disclosed AVBP position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.